Earnings Feed
Start Free
Home/Filings/4/0000914190-13-000799
4//SEC Filing

Arno Therapeutics, Inc 4

Accession 0000914190-13-000799

CIK 0001195116operating
View on SEC.govCompany Profile

Filed

Nov 5, 7:00 PM ET

Accepted

Nov 6, 4:42 PM ET

Size

11.5 KB

Accession

0000914190-13-000799

Insider Transaction Report

Form 4
Period: 2013-11-04
Arno Therapeutics, IncARNI
HAMILTON WILLIAM F PHD
Director
Transactions
  • Award

    Stock Option (right to buy)

    2013-11-04+68,448→ 68,448 total
    Exercise: $2.40Exp: 2023-11-04→ Common Stock (68,448 underlying)
Holdings

  • Stock Option (right to buy)

    Exercise: $8.00Exp: 2019-09-29→ Common Stock (3,750 underlying)
    3,750

  • 2013 Series E Warrants (right to buy)

    Exercise: $2.40From: 2013-10-29Exp: 2014-10-31→ Common Stock (20,833 underlying)
    20,833

  • 2013 Series D Warrants (right to buy)

    Exercise: $4.00From: 2013-10-29Exp: 2018-10-29→ Common Stock (20,833 underlying)
    20,833

  • Common Stock

    22,079

  • Stock Option (right to buy)

    Exercise: $8.00Exp: 2020-11-05→ Common Stock (1,250 underlying)
    1,250
Footnotes (3)
  • [F1]Currently exercisable.
  • [F2]Vests in three equal annual installments commencing 11/5/11.
  • [F3]Vests in equal 36-monthly installments commencing 12/4/13.

Documents

1 file

Issuer

Arno Therapeutics, Inc

CIK 0001195116

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001195116

Filing Metadata

Form type
4
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 4:42 PM ET
Size
11.5 KB
View on SEC.gov